Publications, Abstracts and Posters

• Guo, Jeff J., Curkendall, S, Jones, Judith K., Fife, Daniel, Goehring, E. She, Dewei. Compliance with Label Changes of Cisapride and Contraindicated Drugs . Pharmacoepidemiology and Drug Safety 2003; Vol 12 pp: 295-302.
  
• Dragone, Mary Alice, Bush, Patricia L., Jones, Judith K., Bearison, David L., Kamani, Sharmila. Development and evaluation of an interactive CD-RIM for children with leukemia and their families. Patient Education and Counseling 2002; 46:297-307


• Slough, Candice L., Miday, Robert K. Zorich, Nora L. and Jones, Judith K. Postmarketing surveillance of New Food Ingredients: Design and Implementation of the Program for the Fat Replacer Olestra. Regulatory Toxicology and Pharmacology 2001; 33:218-223.
  
• Roswell R, Van Diepen LR, Jones JK, Hicks WE. "Adverse Drug Reactions" The Lancet. 2001. Feb 17; 357.
   
• Jones, J. K., "The Role of Data Mining Technology for Identifying Signals of Possible Adverse Drug Reactions: Value and Limitations." Current Therapeutic Research 2001. Vol. 62, No. 9, pp. 664-672.
  
• Jones, J.K., "Pharmacogenetics and pharmacoepidemiology", Pharmacoepidemiology and Drug Safety 2001. Vol.10, pp. 457-461.
  
• Jones J. K.; Guo J. J Fife D., Curkendall S., Goehring E., and Shannon M. "Pharmacies as Potential Intervention Points: Cisapride and Contraindicated Drugs", JAMA 2001 Vol. 286, No. 13, pp. 1607-1609
  
• Jones, Judith K. MD, PhD. Mary Alice Dragone. Patricia J. Bush. Sharmila Kamani. "An Interactive CD-Rom to Provide Information on Leukemia to Children and Their Families". The Patients Network. Volume 5 Number 3. 2000. 19-20.
  
• Suarez, Ann P. MPH. Judy A. Staffa PhD, RPh Peter Fletcher MD and Judith K. Jones MD, PhD. "Reasons for Discontinuation of Newly Prescribed Antihypertensive Medications: Methods of a Pilot Study Using Computerized Patient Records". Pharmacoepidemiology and Drug Safety. Volume 9 Number 5. 2000. 405-416.
  
• Suarez AP, Staffa JA, Fletcher P, Jones JK: Reason for Discontinuation of Newly Prescribed Antihypertensive Medications: Methods of a Pilot Study using Computerized Patient Records. Pharmacoepidemiology and Drug Safety 2000; 9: 405-415.
  
• Jones JK, Miwa LJ: The epidemiology of non-gastrointestinal adverse reactions from OTC analgesics. In: Rainsford KD, Powanda MC (Eds.): Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs, Proceedings of the International Conference held at The South Francisco Conference Center, San Francisco, CA, USA on Monday 17^th March 1997, Kluwer Academic Publishers, Dordrecht, The Netherlands:1998: 47-72.
  
• Keyser MS, Crawley JA, Goldberg GA, Shaw MM: Gastroesophageal Reflux Disease in Managed Care Setting: Professional, Facility, and Pharmacy Charges. Journal of Managed Care Pharmacy. January/February, 1998; 4(1): 64-70.
  
• Dai WS, Xue S, Yoo K, Jones JK, LaBraico J: An Investigation of the Safety of Midazolam Use in Hospital. Pharmacoepidemiology and Drug Safety 1997; 6:79-87.
  
• Miwa LJ, Jones JK, Pathiyal A, Hatoum H: Value of Epidemiologic Studies in Determining the True Incidence of Adverse Events: The NSAID Story. Archives of International Medicine 1997, 157:2129-2136.
  
• Pathiyal A, Hylan TR, Jones JK, Davtian D, Sverdlov LS, Keyser M. Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in the Netherlands: a multivariate analysis. Clinical Therapeutics. 1997; 19(4): 798-810.
  
• Floor MK, Jones JK, Devlies J: MEDIDOC -- a Computerized Patient Record for Primary Care. Requirements and Benefits of a CPR in the Context of Disease Prevention and Health Promotion. In Tamura M (ed): Health Tactics in the 21st Century. International Health Evaluation Association; 1995:351-355.
  
• Floor MK: A Voice-Activated Computer System for Data Collection in Hypertension Clinical Trials. 1995; 2:334-339. (Abstract).
  
• Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP: Discontinuation of and Changes in Treatment after Start of New Courses of Antihypertensive Drugs: a Study of a United Kingdom Population. British Medical Journal 1995;311:293-295.
  
• Kurata JH, Overhage M, Gabrieli E, Jones JK: International Data Standards for Hospital-Based Drug Surveillance. MD Computing 1995; 12(1): 50-57.
  
• Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK: Risk of Selected Serious Cardiac Events Among New Users of Antihistamines. Clinical Therapeutics 1995;17(6):1062-1077.
  
  
• Jones JK: Inpatient Data Bases, in Strom BL (ed): Pharmacoepidemiology. Chichester, J. Wiley & Sons; 1994:257-276.
  
• Jones JK, Gable CB, Kennedy C, Rajan M: Chronic Sinusitis: Temporal Occurrence and Relationship to Medical Claims for Upper Respiratory Infections and Allergic Rhinitis. Pharmacoepidemiology and Drug Safety 1994; 3:337-349.
  
• Jones JK, Miwa LJ, Mann RD: Identifying Resources for Assessing Use and Effects of Pharmaceuticals and Other Medical Products in the European Community. European Medicines Research 1994; 391-407.
  
• Jones JK, Staffa J: Estimation of the Frequency of Warfarin-Associated Necrosis in a Large In-patient Record-linked Database. Pharmacoepidemiology and Drug Safety 1993; 2:115-125.
  
• Jones JK: The Status and Future of Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety 1992; 1:99-103.
  
• Jones JK: Assessing Potential Risk of Drug: The Elusive Target. Annals of Internal Medicine 1992; 117(8): 691-692.
  
• Jones JK: Causality Assessment of Suspected Adverse Drug Reactions: a Transatlantic View. Pharmacoepidemiology and Drug Safety 1992; 1; 251-160.
  
• Jones JK: Hospital Data Sources: Drug Epidemiology and Post-Marketing Surveillance 1992: 83-90


• Staffa JA, Newschaffer CJ, Jones JK, Miller V: Progestins and Breast Cancer: An Epidemiologic Review. Fertility and Sterility 1992; 57(3): 473-476.
  
• Jones JK, Staffa JA, Simison D, Floor M, Dinkel R. International Data Bases for the Study of Drug Risk. In: Communication in Pharmaceutical Medicine: A Challenge for 1992. Ferran JR, Dal Re JL, Lardinois R, (eds.) Barcelona: J.R. Prous Science Publishers; 1991: 183-191.
  
  
• Keyser MS, Crawley JA, Goldberg GA, Shaw MM: Gastroesophageal Reflux Disease in Managed Care Setting: Charges By Place and Type of Service. Submitted in January, 1997, to Journal of Managed Care Pharmacy, accepted November, 1997; expected publication in March/April, 1998 issue.
  
• Pathiyal A, Jones JK, Hylan TR, Devlies J. Longitudinal Evaluation of Selective Serotonin Reuptake Inhibitor Use in a Primary Care Setting in Belgium. (Submitted to Acta Psychiatrica Scandinavica, 1998).
  
• Suarez AP, Staffa JA, Fletcher P, Jones JK. Reasons for Discontinuation of Newly Prescribed Antihypertensive Medications: Methods and Preliminary Results. (Submitted to Pharmacoepidemiology and Drug Safety, 1998).
  
• Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U. SSRIs Have Broadened the Utilization of Antidepressant Treatment in Accordance with Recommendations. (Submitted to Journal of Affective Disorders, 1997)
  
• Pathiyal A, Hylan TR, Quik R, Jones JK. Antidepressant Use and Resource Utilization in the General Practitioner Setting in The Netherlands. (Submitted to Pharmacoepidemiology and Drug Safety, 1997).
  
• Rossiter LF, Whitehurst-Cook MY, Small RE, Shasky C, Penberthy L, Okasha A, Green J, Ibrahim I, Bovbjerg VE, Jones JK, Thomas S.: Incentives and Delegated Authority: The Next Models of Medicaid and Managed Care. Submitted to Health Care Financing Review, 1997.